The significant findings from the Scout-HCM study reveal the efficacy of mavacamten in addressing left ventricular outflow tract obstruction in adolescent patients with hypertrophic cardiomyopathy.
The significant findings from the Scout-HCM study reveal the efficacy of mavacamten in addressing left ventricular outflow tract obstruction in adolescent patients with hypertrophic cardiomyopathy.